Baytacare Pharmaceutical Co., Ltd. announced unaudited consolidated earnings results for the first quarter ended March 31, 2019. For the quarter, the company reported turnover of RMB 7,212,000. Operating loss was RMB 821,000 against RMB 8,392,000 a year ago. Loss after income tax expense was RMB 1,064,000 against RMB 8,432,000 a year ago. Basic loss per share of 0.17 cents against 1.00 cents a year ago.